nIcal Phase I Phase II Phase III APPROVEC Launched by Spectrum Pilorm. in 3Q13 PhaSe ill trial started in 4C113 Phasell testing in China in 2H13 Marqibo, is a liposomal formulation for the treatment of adult patients with relapsed Leukaemia (second or greater relapse) or whose disease has progressed